Concepedia

Marianne Vogel

MV

Statistics

Publications

9

Citations

333

H-Index

9

Active since

1993

Affiliations

Ludwig-Maximilians-Universität München(Current)

München Klinik

Marianne Vogel is an author at Ludwig-Maximilians-Universität München specializing in oncology, molecular oncology, and life sciences.

Publications per year

1993–2017

9

Publications

9

Nelfinavir induces the unfolded protein response in ovarian cancer cells, resulting in ER vacuolization, cell cycle retardation and apoptosis

Ansgar Brüning, Petra Burger, Marianne Vogel et al. · Cancer Biology & Therapy · 2009 · 65 citations · Full text

Medicine, Oncology, Pharmacology +16

The nucleoside antagonist cordycepin causes DNA double strand breaks in breast cancer cells

Hong Jue Lee, Petra Burger, Marianne Vogel et al. · Investigational New Drugs · 2012 · 64 citations

Life Sciences, Molecular Biology, Oncology +16

Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with taxol and conventional antineoplastic agents

Marianne Vogel, Susan G. Hilsenbeck, H. Depenbrock et al. · European Journal of Cancer · 1993 · 44 citations

Medicine, Oncology, Pharmacology +15

Bortezomib treatment of ovarian cancer cells mediates endoplasmic reticulum stress, cell cycle arrest, and apoptosis

Ansgar Brüning, Petra Burger, Marianne Vogel et al. · Investigational New Drugs · 2008 · 43 citations

Life Sciences, Cell Biology, Oncology +17

Bortezomib Targets the Caspase-Like Proteasome Activity in Cervical Cancer Cells, Triggering Apoptosis That Can be Enhanced by Nelfinavir

Ansgar Brüning, Marianne Vogel, Ioannis Mylonas et al. · Current Cancer Drug Targets · 2011 · 39 citations

Life Sciences, Oncology, Pharmacology +17

1–5 of 9